Ranitidine Tablets, USP 150 mg , a). 4 count bottle (NDC 70934-017-04), b). 20-c Supply Disruption — Denton Pharma, Inc. (Moderate
Ranitidine Tablets, USP 150 mg , a). 4 count bottle (NDC 70934-017-04), b). 20-c Supply Disruption — Denton Pharma, Inc. (Moderate is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Ranitidine Tablets, USP 150 mg , a). 4 count bottle (NDC 70934-017-04), b). 20-c; Manufacturer: Dento
| Drug name | Ranitidine Tablets, USP 150 mg , a). 4 count bottle (NDC 70934-017-04), b). 20-c |
|---|---|
| Manufacturer | Denton Pharma, Inc. |
| Recall/Disruption reason | CGMP Deviations: Presence of NDMA impurity detected in product. |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-0794-2020 |
| Initiation date | 20191220 |
| Quantity affected | 1,341 bottles |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →